Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,389 articles

Articles by Daniel Marsh

CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally
Markets

CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally

CRISPR Therapeutics shares surged 12% in New York trading, buoyed by a sector-wide gene-editing rally and Eli Lilly's $1.9 billion deal with Ascidian Therapeutics.

CRSP LLY NTLA BEAM EDIT XBI
Keel Infrastructure Tumbles as AI Data Center Hopes Face Permitting Hurdles
Markets

Keel Infrastructure Tumbles as AI Data Center Hopes Face Permitting Hurdles

Keel shares slipped 1.7% after a 98% monthly surge, as the market focuses on whether the company can convert its power-rich sites into AI data center leases amid Q1 losses.

APLD
AT&T Stock Slides on SpaceX Starlink Threat and Regulatory Setback
Markets

AT&T Stock Slides on SpaceX Starlink Threat and Regulatory Setback

AT&T shares fell 3.7% on Thursday after Oppenheimer downgraded the stock, warning that SpaceX's Starlink could disrupt the US communications market. The Supreme Court also upheld FCC fines against AT&T.

T TMUS VZ
Nu Holdings Rises on $1B Buyback but Analysts Stay Wary
Markets

Nu Holdings Rises on $1B Buyback but Analysts Stay Wary

Nu Holdings shares rose 4% on a $1 billion buyback announcement, but analysts remain cautious amid CFO change and credit concerns.

NU
Redwire Shares Surge on Space Strawberry Contract
Markets

Redwire Shares Surge on Space Strawberry Contract

Redwire shares soared 14.6% to $21.33 after winning a contract to grow strawberries on the ISS, but the undisclosed deal value leaves near-term financial impact uncertain.

RDW RKLB PL ASTS
Foxx Development Stock Skyrockets Amid Filing Activity and Compliance Boost
Markets

Foxx Development Stock Skyrockets Amid Filing Activity and Compliance Boost

Foxx Development shares surged over 100% on heavy Nasdaq volume, fueled by compliance news and ownership shifts, though the company warned of going-concern risks.

FOXX
Snap Stock Rises on Credit Rating Upgrade as Debt Markets Signal Confidence
Markets

Snap Stock Rises on Credit Rating Upgrade as Debt Markets Signal Confidence

Snap shares jumped almost 7% after S&P Global Ratings raised its credit rating to BB-, citing lower leverage, improved free cash flow, and expected revenue gains.

SNAP META PINS QQQ SPY
Dow Surges as Rotation Out of AI Lifts Healthcare and Financials
Markets

Dow Surges as Rotation Out of AI Lifts Healthcare and Financials

The Dow rallied over 700 points as money flowed into healthcare and financials, while AI and chip stocks slumped. Oil dropped nearly 3% ahead of the jobs report.

AVGO MRVL AMD CRWD GLD USO
Dow rises as AI chip stocks stumble; Broadcom plunges 15%
Markets

Dow rises as AI chip stocks stumble; Broadcom plunges 15%

Broadcom shares tumbled 15% after missing revenue expectations and holding its AI-chip sales forecast steady, dragging the Nasdaq lower and sparking a selloff in chip stocks.

AVGO GOOGL META MRVL AMD MU QCOM UNH
Micron Stock Plunges as AI Chip Selloff Intensifies
Markets

Micron Stock Plunges as AI Chip Selloff Intensifies

Micron Technology dropped 8.3% after Broadcom's revenue miss triggered a chip selloff, but analysts say memory shortages could persist for years.

MU AVGO AMD WDC SOXX QQQ
UnitedHealth Rises as Analysts See Easing Medical Costs
Markets

UnitedHealth Rises as Analysts See Easing Medical Costs

UnitedHealth shares climbed 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target, citing easing medical costs and a favorable Q2 setup.

UNH ELV CI HUM
Splash Beverage Surges 71% on NYSE Compliance Plan Filing
Markets

Splash Beverage Surges 71% on NYSE Compliance Plan Filing

Splash Beverage Group (SBEV) shares soared 71% to $0.2420 after submitting a plan to regain NYSE American compliance. The stock traded at $0.3650 premarket as investors weigh survival efforts against an expired Medterra CBD deal, revenue collapse to $4,224, and thin cash reserves.

SBEV